Cart (0 Items)
Your cart is currently empty.
View ProductsIndatuximab Biosimilar – Anti-SDC1, CD138 mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG4, kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Indatuximab Biosimilar - Anti-SDC1, CD138 mAb - Research Grade |
|---|---|
| Source | CAS 1238517-16-2 |
| Species | Chimeric |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Indatuximab,BT-062,nBT062-DM4,SDC1, CD138,anti-SDC1, CD138 |
| Reference | PX-TA1277 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG4-kappa |
| Clonality | Monoclonal Antibody |
Description of Indatuximab Biosimilar - Anti-SDC1, CD138 mAb - Research Grade
General information on Anti-SDC1/CD138[Homo sapiens] (Indatuximab) Monoclonal Antibody
Indatuximab is investigated for the treatment of Relapsed or Refractory Multiple Myeloma.
Related products
Antigen
CD138 Recombinant Protein
PX-P4106 420€
ELISA
Indatuximab ELISA Kit
KPTX205 1300€Contact us
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.